Every one of those 1 sits in a single category, health-it. dr. Adin Nulkhasanah, Sp.S, MARS is most often covered alongside Articura (PT Articura Tech Indonesia), which appears in 1 of these 1 story. At 7, the average consequence score sits above the same-window beat average of 6.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about dr. Adin Nulkhasanah, Sp.S, MARS
Every one of those 1 sits in a single category, health-it. dr. Adin Nulkhasanah, Sp.S, MARS is most often covered alongside Articura (PT Articura Tech Indonesia), which appears in 1 of these 1 story. At 7, the average consequence score sits above the same-window beat average of 6. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline. We currently track 1 Healthcare story that mention dr. Adin Nulkhasanah, Sp.S, MARS, all published on July 27, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering dr. Adin Nulkhasanah, Sp.S, MARS. Shared-story counts are live from our verified record — not editorial picks.
PT Articura Tech Indonesia launches a sovereign healthcare AI platform with five partners spanning national neurology, pharmacy research, pediatrics, primary care, and digital health. The initiative aims to develop locally tailored AI while ensuring data sovereignty, supported by the Ministry of Health's National AI Healthcare Working Group. For healthcare providers, this could mean improved diagnostic support and more equitable AI access across Indonesia's fragmented delivery system.
dr. Adin Nulkhasanah, Sp.S, MARS is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.
